Archives of Disease in Childhood - Fetal and Neonatal Edition 2008;93:F94-F99
ORIGINAL ARTICLES
Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial
Department of Paediatrics, China Medical University Hospital, Taichung, Taiwan
Correspondence to:
Dr B-H Su, Department of Paediatrics, China Medical University Hospital, Taiwan, 2 Yuh Der Rd, Taichung 404, Taiwan; bais{at}ms49.hinet.net
Background: To date there is no firm conclusion as to the efficacy and safety of ibuprofen compared with indometacin for patent ductus arteriosus (PDA) closure in extremely premature infants.
Objective: To conduct a randomised controlled trial to better address this problem.
Methods: 119 infants (gestational age 
28 weeks) with respiratory distress syndrome and PDA confirmed by echocardiography were randomly assigned to receive either indometacin (0.2 mg/kg) or ibuprofen (10 mg/kg), starting at <24 hours of life, followed by half these first doses within 48 hours at 24-hour intervals if indicated by echocardiographic PDA flow pattern.
Results: The PDA closure rate and the doses of drug (mean (SD)) were similar in both groups: 53/60 (88.3%) and 1.9 (1.5) mg/kg in infants given ibuprofen, and 52/59 (88.1%) and 1.9 (1.7) mg/kg in infants given indometacin. No significant difference was found in the numbers of infants requiring surgical ligation, and the levels of post-treatment serum creatinine and urea nitrogen between the two groups. Although not significantly different, more infants (9/59 (15.3%)) treated with indometacin tended to develop oliguria (<1 ml/kg/h) than those treated with ibuprofen (4/60 (6.7%)). There were no significant differences in side effects or complications between the two groups.
Conclusions: Ibuprofen is as effective as indometacin for the early-targeted PDA treatment in extremely premature infants, without increasing the incidence of complications. When the echocardiographic PDA flow pattern was used as a guide for PDA treatment, fewer doses of drugs were needed to achieve acceptable closing rates.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
eLetters:
Read all eLetters
- Ibuprofen versus indomethacin in the treatment of persistent patent ductus arteriosus (PDA): What’s
- Yoginder Singh
- Fetal Neonatal Ed. Online, 30 Mar 2009 [Full text]
- Ibuprofen versus indomethacin in the treatment of persistent patent ductus arteriosus (PDA)
- Yoginder Singh
- Fetal Neonatal Ed. Online, 30 Mar 2009 [Full text]
- Full Text
- Full Text (PDF)
- erratum
-
All Versions of this Article:
adc.2007.120584v1
93/2/F94 most recent - Submit a response
- Read responses to this article
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in ADC Online
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
